PAD and Claudication
From the Journals
Add AFib to noncardiac surgery risk evaluation: New support
Preexisting atrial fibrillation should again be part of pre–noncardiac surgery cardiac risk assessment, argues a new report.
News from the FDA/CDC
FDA update: Higher late mortality with paclitaxel-coated devices
From the Journals
New vascular 0 + 5 training programs yield fewer PAD cases
From the Journals
Ask patients, not devices, about impact of PAD
News from the FDA/CDC
FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD
The FDA is investigating data from a recent meta-analysis of increased long-term mortality risk from paclitaxel-coated balloons and paclitaxel-...
Conference Coverage
Drug-coated balloon advantage persists in femoral artery disease
The 5-year results from IN.PACT are consistent with those previously reported at 1, 2, and 3 years.
From the Journals
Frailty tied to higher mortality after major vascular surgery
From the Journals
Claudication, CLI differ significantly in hospital readmission, costs, mortality
From the Journals
Tracking 90-day vascular surgery outcomes: The coming new normal?
From the Journals
Fewer groin infections with closed incision negative pressure therapy after vascular surgery
Conference Coverage
Femoral artery endarterectomy still ‘gold standard’
CHICAGO – Expert: Endovascular therapies for CFA need better supporting evidence.